Filed: 2/14/2025ACC: 0001892688-25-000086
📋 What this filing means
DIADEMA PARTNERS LP filed this quarterly 13F‑HR report disclosing 86 equity positions with a total reported market value of $233.05M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
86
Positions
$233.05M
Total AUM (reported)
10.88M
Total Shares
Allocation by class
COM$158.22M67.9%
S&P BIOTECH$18.01M7.7%
SPONSORED ADS$10.18M4.4%
COMMON STOCK$8.44M3.6%
SPONSORED ADR$8.26M3.5%
COM NEW$8.05M3.5%
NAMEN AKT$7.51M3.2%
Portfolio Concentration
Top 3$58.90M25.3%
4–10$61.85M26.5%
11–25$61.64M26.4%
Rest$50.67M21.7%
Top 3 weight
25.3%
Top 10 weight
51.8%
Voting Authority Distribution
Total shares with voting rights: 10.88M
Sole
Full voting authority
10.88M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole86
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings86
Rows:
VERTEX PHARMACEUTICALS INC
SOLEShares57.40K
TypeSH
Market value$23.11M
9.92%
Sole
57.40K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares200K
TypeSH
Market value$18.01M
7.73%
Sole
200K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares100K
TypeSH
Market value$17.77M
7.62%
Sole
100K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares341.99K
TypeSH
Market value$15.37M
6.60%
Sole
341.99K
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares160K
TypeSH
Market value$9.05M
3.88%
Sole
160K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares110.10K
TypeSH
Market value$8.44M
3.62%
Sole
110.10K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares190.80K
TypeSH
Market value$7.51M
3.22%
Sole
190.80K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares247.81K
TypeSH
Market value$7.46M
3.20%
Sole
247.81K
Shared
0.00
None
0.00
INSMED INC
SOLEShares106.34K
TypeSH
Market value$7.34M
3.15%
Sole
106.34K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares300K
TypeSH
Market value$6.68M
2.86%
Sole
300K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares157.80K
TypeSH
Market value$6.64M
2.85%
Sole
157.80K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares64.19K
TypeSH
Market value$5.60M
2.40%
Sole
64.19K
Shared
0.00
None
0.00
HALOZYME THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$4.78M
2.05%
Sole
100K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares75K
TypeSH
Market value$4.20M
1.80%
Sole
75K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares315K
TypeSH
Market value$4.17M
1.79%
Sole
315K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares96.16K
TypeSH
Market value$4.16M
1.78%
Sole
96.16K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares30K
TypeSH
Market value$3.93M
1.69%
Sole
30K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares243.95K
TypeSH
Market value$3.86M
1.66%
Sole
243.95K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares100K
TypeSH
Market value$3.73M
1.60%
Sole
100K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares43.70K
TypeSH
Market value$3.65M
1.57%
Sole
43.70K
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares258.70K
TypeSH
Market value$3.57M
1.53%
Sole
258.70K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares25.28K
TypeSH
Market value$3.48M
1.49%
Sole
25.28K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares102K
TypeSH
Market value$3.35M
1.44%
Sole
102K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares60K
TypeSH
Market value$3.32M
1.43%
Sole
60K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$3.19M
1.37%
Sole
100K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERTEX PHARMACEUTICALS INCSOLE | COM | 57.40K | SH | $23.11M 9.92% | 57.40K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 200K | SH | $18.01M 7.73% | 200K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 100K | SH | $17.77M 7.62% | 100K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 341.99K | SH | $15.37M 6.60% | 341.99K | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 160K | SH | $9.05M 3.88% | 160K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 110.10K | SH | $8.44M 3.62% | 110.10K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 190.80K | SH | $7.51M 3.22% | 190.80K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 247.81K | SH | $7.46M 3.20% | 247.81K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 106.34K | SH | $7.34M 3.15% | 106.34K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 300K | SH | $6.68M 2.86% | 300K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 157.80K | SH | $6.64M 2.85% | 157.80K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 64.19K | SH | $5.60M 2.40% | 64.19K | 0.00 | 0.00 |
HALOZYME THERAPEUTICS INCSOLE | COM | 100K | SH | $4.78M 2.05% | 100K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 75K | SH | $4.20M 1.80% | 75K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 315K | SH | $4.17M 1.79% | 315K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 96.16K | SH | $4.16M 1.78% | 96.16K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 30K | SH | $3.93M 1.69% | 30K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 243.95K | SH | $3.86M 1.66% | 243.95K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 100K | SH | $3.73M 1.60% | 100K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 43.70K | SH | $3.65M 1.57% | 43.70K | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 258.70K | SH | $3.57M 1.53% | 258.70K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 25.28K | SH | $3.48M 1.49% | 25.28K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 102K | SH | $3.35M 1.44% | 102K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 60K | SH | $3.32M 1.43% | 60K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 100K | SH | $3.19M 1.37% | 100K | 0.00 | 0.00 |
Page 1 of 4